机译:揭开罗萨蒂石:从第一届年度关键要素的报告转化为临床前临床前临床
Center for Advanced Translational Stroke Science University of Kentucky;
Center for Advanced Translational Stroke Science University of Kentucky;
Department of Neurosurgery Keck School of Medicine University of Southern California;
Department of Neurology David Geffen School of Medicine University of California at Los Angeles;
Department of Neurology University of Miami Miller School of Medicine;
Department of Neurology Oregon Health &
Science University;
Department of Neurology Yale University School of Medicine;
National Institute of Neurological Disorders and Stroke National Institutes of Health;
Department of Neurology Harvard Medical School;
Center for Advanced Translational Stroke Science University of Kentucky;
Clinical trials; Animal models; Reverse translation; Brain ischemia; Thrombectomy;
机译:揭开罗萨蒂石:从第一届年度关键要素的报告转化为临床前临床前临床
机译:临床前临床翻译失败和卒中治疗中临床试验的现状:简要审查
机译:临床前模型中与抗肿瘤活性相关的免疫STAT3敲低可转化为临床样品,表明免疫调节有助于治疗性STAT3 ASO AZD9150的临床活性
机译:高强度超声治疗的翻译研究:临床前测试的新技术
机译:中风后恢复的临床前评估:影响预后的因素。
机译:发现罗塞塔石碑:第一届年度会议关于中风治疗从临床前到临床的关键要素报告
机译:亚太中风会议2017年。亚太卒中组织(APSO)年会的摘要与澳大利亚卒中社会相结合。中国南京,2017年10月26日至28日:摘要